Show simple item record

dc.contributor.authorManu, K.
dc.contributor.authorShanmugam, M.
dc.contributor.authorRamachandran, L.
dc.contributor.authorLi, F.
dc.contributor.authorSiveen, K.
dc.contributor.authorChinnathambi, A.
dc.contributor.authorZayed, M.
dc.contributor.authorAlharbi, S.
dc.contributor.authorArfuso, Frank
dc.contributor.authorKumar, Alan Prem
dc.contributor.authorAhn, K.
dc.contributor.authorSethi, G.
dc.date.accessioned2018-05-18T07:57:02Z
dc.date.available2018-05-18T07:57:02Z
dc.date.created2018-05-18T00:23:12Z
dc.date.issued2018
dc.identifier.citationManu, K. and Shanmugam, M. and Ramachandran, L. and Li, F. and Siveen, K. and Chinnathambi, A. and Zayed, M. et al. 2018. Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]. Cancer Letters. 420.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/67036
dc.identifier.doi10.1016/j.canlet.2018.01.003
dc.description.abstract

© 2018 The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.

dc.publisherElsevier
dc.titleCorrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
dc.typeJournal Article
dcterms.source.volume420
dcterms.source.issn0304-3835
dcterms.source.titleCancer Letters
curtin.departmentSchool of Pharmacy and Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record